NDC 73024-429 Optimel Manuka Forte Eye Gel


NDC Product Code 73024-429

NDC CODE: 73024-429

Proprietary Name: Optimel Manuka Forte Eye Gel What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.

Non-Proprietary Name: Glycerin What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

Drug Use Information

Drug Use Information
The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.

This product is used to relieve occasional constipation. Glycerin belongs to a class of drugs known as hyperosmotic laxatives. It works by drawing water into the intestines. This effect usually results in a bowel movement within 15 to 60 minutes. For adults, the normal frequency of bowel movements varies from once daily to 1 to 2 times weekly. For preschool-aged children, the normal frequency of bowel movements varies from once daily to once every other day. Constipation is best treated by drinking plenty of fluids, eating foods high in fiber, and exercising regularly.

NDC Code Structure

  • 73024 - Melcare Biomedical Pty Ltd

NDC 73024-429-10

Package Description: 1 BOTTLE, DROPPER in 1 CARTON > 10 mL in 1 BOTTLE, DROPPER

NDC Product Information

Optimel Manuka Forte Eye Gel with NDC 73024-429 is a a human over the counter drug product labeled by Melcare Biomedical Pty Ltd. The generic name of Optimel Manuka Forte Eye Gel is glycerin. The product's dosage form is gel and is administered via ophthalmic form.

Labeler Name: Melcare Biomedical Pty Ltd

Dosage Form: Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Optimel Manuka Forte Eye Gel Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • GLYCERIN 2 mg/mL

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • HONEY (UNII: Y9H1V576FH)
  • WATER (UNII: 059QF0KO0R)
  • ACACIA (UNII: 5C5403N26O)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Ophthalmic - Administration to the external eye.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Melcare Biomedical Pty Ltd
Labeler Code: 73024
FDA Application Number: part349 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 07-19-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Optimel Manuka Forte Eye Gel Product Label Images

Optimel Manuka Forte Eye Gel Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index


Drug Facts

Active Ingredients

Glycerin 0.2%




  • For the temporary relief of burning and irritation due to dryness of the eye. for use as a protectant against further irritation or to relieve dryness of the eye.


For external use only

Do Not Use

  • If hypersensitive to bee products or food gums.if solution changes color or becomes cloudy.if box seal is broken or packaging is damaged.serious conditions should be managed under the supervision of a doctor.

When Using This Product

  • To avoid contamination, do not touch tip of container to any surface.replace cap after using.do not overtighten cap.remove contact lenses before using.wait at least 10 minutes before contact lens insertion.Initial stinging and redness on drop application is to be expected.

Stop Use And Ask A Doctor If

  • You experience eye pain changes in visioncontinued redness or irritation of the eye.condition worsens or persists for more than 72 hours.you have any reaction other than transient stinging and redness.You experience eye pain, change in vision, continued redness or irritation of the eye.Condition worsens

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away.


  • Wash hands.Remove cap, do not allow nozzle to touch any surface.Instill 1 drop to the inner corner of the affected OR dispense onto tip of cotton bud and gently apply along lower lid margin up to 3 times daily or as directed.

Other Information

  • Single patient use only.Discard 2 months after opening.Store below 25°C (77°F).Tube is oversized to allow contents to expand during sterilization.

Inactive Ingredients

Honey (
Leptospermum spp.), Gum Arabic, Water.


Web: www.melcare.com

Email: info@melcare.com

Phone: 8557082611

* Please review the disclaimer below.